WEKO3
アイテム
Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome
http://hdl.handle.net/10069/39981
http://hdl.handle.net/10069/399812b1a8614-9bd2-42d9-802b-20b5061dd4d8
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
IntMed59_1081.pdf (1.9 MB)
|
|
| Item type | 学術雑誌論文 / Journal Article(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2020-05-19 | |||||
| タイトル | ||||||
| タイトル | Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | myelodysplastic syndromes | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | secondary pulmonary alveolar proteinosis | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | azacitidine | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | umbilical cord blood transplantation | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | journal article | |||||
| 著者 |
Hashimoto, Miki
× Hashimoto, Miki× Itonaga, Hidehiro× Nannya, Yasuhito× Taniguchi, Hirokazu× Fukuda, Yuichi× Furumoto, Takafumi× Fujioka, Machiko× Kasai, Sachie× Taguchi, Masataka× Taniguchi, Hiroaki× Sato, Shinya× Sawayama, Yasushi× Atogami, Sunao× Iwasaki, Keisuke× Hata, Tomoko× Soda, Hiroshi× Moriuchi, Yukiyoshi× Nakata, Koh× Ogawa, Seishi× Miyazaki, Yasushi |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Secondary pulmonary alveolar proteinosis (sPAP) is a complication of myelodysplastic syndrome (MDS). A 60-year-old woman was diagnosed with MDS with excess blasts-1. Fifty-four months after the initial diagnosis, treatment with azacitidine was initiated. Seventy-three months after the diagnosis, a bone marrow examination revealed increased myeloblasts, at which time computed tomography showed diffuse ground-glass opacities and interlobular septal thickening in the bilateral lower lung fields. A lung biopsy revealed the presence of PAP; therefore, the clinical diagnosis of MDS/sPAP was confirmed. Careful attention should be paid to the development of sPAP in MDS patients with pulmonary lesions during azacitidine treatment. | |||||
| 書誌情報 |
Internal Medicine 巻 59, 号 8, p. 1081-1086, 発行日 2020-04-20 |
|||||
| 出版者 | ||||||
| 出版者 | The Japanese Society of Internal Medicine | |||||
| 出版者別言語 | ||||||
| 値 | 日本内科学会 | |||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 09182918 | |||||
| EISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 13497235 | |||||
| DOI | ||||||
| 関連タイプ | isIdenticalTo | |||||
| 識別子タイプ | DOI | |||||
| 関連識別子 | 10.2169/internalmedicine.3770-19 | |||||
| 権利 | ||||||
| 権利情報 | c 2020 The Japanese Society of Internal Medicine. The Internal Medicine is an Open Access journal distributed under license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). | |||||
| 著者版フラグ | ||||||
| 出版タイプ | VoR | |||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
| 引用 | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | Internal Medicine, 59(8), pp.1081-1086; 2020 | |||||
